Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization.

[1]  Jun Liu,et al.  Patient, Physician, and Payment Predictors of Statin Adherence , 2010, Medical care.

[2]  C. Vogeli,et al.  Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions , 2010, Journal of General Internal Medicine.

[3]  K. Alexander,et al.  Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome. , 2009, The American journal of cardiology.

[4]  M. Brookhart,et al.  Measuring concurrent adherence to multiple related medications. , 2009, The American journal of managed care.

[5]  Maria Mori Brooks,et al.  A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.

[6]  M. Brookhart,et al.  Impact of Statin Use on Outcomes After Coronary Artery Bypass Graft Surgery , 2008, Circulation.

[7]  T. Brennan,et al.  Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. , 2008, American heart journal.

[8]  P Michael Ho,et al.  Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. , 2008, American heart journal.

[9]  H. Krumholz,et al.  Association of early follow-up after acute myocardial infarction with higher rates of medication use. , 2008, Archives of internal medicine.

[10]  Haynes Rb,et al.  Interventions for enhancing medication adherence (Review) , 2008 .

[11]  D. Solomon,et al.  Patterns and predictors of statin use after coronary artery bypass graft surgery. , 2007, The Journal of thoracic and cardiovascular surgery.

[12]  M Alan Brookhart,et al.  Physician follow-up and provider continuity are associated with long-term medication adherence: a study of the dynamics of statin use. , 2007, Archives of internal medicine.

[13]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[14]  D. Alter,et al.  Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. , 2007, JAMA.

[15]  S. Normand,et al.  Positive predictive value of the diagnosis of acute myocardial infarction in an administrative database , 1999, Journal of General Internal Medicine.

[16]  E. Antman,et al.  Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. , 2007, Health affairs.

[17]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[18]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[19]  R. Califf,et al.  Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease , 2006, Circulation.

[20]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[21]  L. Osterberg,et al.  Adherence to medication. , 2005, The New England journal of medicine.

[22]  D. Singer,et al.  Impact of concurrent medication use on statin adherence and refill persistence. , 2004, Archives of internal medicine.

[23]  Lynn A Smaha,et al.  The American Heart Association Get With The Guidelines program. , 2004, American heart journal.

[24]  S. Piñeros,et al.  Adherence with statin therapy in secondary prevention of coronary heart disease in veterans administration male population. , 2003, The American journal of cardiology.

[25]  Peter C Austin,et al.  A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. , 2002, American heart journal.

[26]  M. Weinstein,et al.  Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.

[27]  Robert Parrish,et al.  Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.

[28]  A. Gawlinski,et al.  Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP). , 2001, The American journal of cardiology.

[29]  B. Horne,et al.  Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. , 2001, The American journal of cardiology.

[30]  H. S. Lau,et al.  Validation of pharmacy records in drug exposure assessment. , 1997, Journal of clinical epidemiology.

[31]  D A Savitz,et al.  Recall accuracy for prescription medications: self-report compared with database information. , 1995, American journal of epidemiology.